These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33037426)
1. Feasibility of upfront mobile money transfers for transportation reimbursement to promote retention among patients receiving lymphoma treatment in Malawi. Ellis GK; Manda A; Topazian H; Stanley CC; Seguin R; Minnick CE; Tewete B; Mtangwanika A; Chawinga M; Chiyoyola S; Chikasema M; Salima A; Kimani S; Kasonkanji E; Mithi V; Kaimila B; Painschab MS; Gopal S; Westmoreland KD Int Health; 2021 Apr; 13(3):297-304. PubMed ID: 33037426 [TBL] [Abstract][Full Text] [Related]
2. Risk factors and reasons for treatment abandonment among children with lymphoma in Malawi. Stanley CC; van der Gronde T; Westmoreland KD; Salima A; Amuquandoh A; Itimu S; Manda A; Mtete I; Butia M; Mpasa A; Wachepa S; Fox P; Wasswa P; Kazembe P; El-Mallawany NK; Gopal S Support Care Cancer; 2018 Mar; 26(3):967-973. PubMed ID: 28986643 [TBL] [Abstract][Full Text] [Related]
3. The feasibility of recruiting and retaining men who have sex with men and transgender women in a multinational prospective HIV prevention research cohort study in sub-Saharan Africa (HPTN 075). Sandfort TG; L Hamilton E; Marais A; Guo X; Sugarman J; Chen YQ; Cummings V; Dadabhai S; Dominguez K; Panchia R; Schnabel D; Zulu F; Reynolds D; Radebe O; Mbeda C; Kamba D; Kanyemba B; Ogendo A; Stirratt M; Chege W; Lucas J; Fawzy M; McKinstry LA; Eshleman SH J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25600. PubMed ID: 33000911 [TBL] [Abstract][Full Text] [Related]
4. Travel time to health-care facilities, mode of transportation, and HIV elimination in Malawi: a geospatial modelling analysis. Palk L; Okano JT; Dullie L; Blower S Lancet Glob Health; 2020 Dec; 8(12):e1555-e1564. PubMed ID: 33220218 [TBL] [Abstract][Full Text] [Related]
5. Cost of transport is a barrier to access to headache care in sub-Saharan Africa: An observational study in an HIV-positive population. Leone M; Giani L; Mwazangati M; Uluduz D; Şaşmaz T; Tolno VT; Guidotti G; Steiner TJ J Neurol Sci; 2024 Sep; 464():123162. PubMed ID: 39146880 [TBL] [Abstract][Full Text] [Related]
6. Clinic transfers and engagement in HIV care during the perinatal period across a network of healthcare centers in Lilongwe, Malawi. Bengtson AM; Kumwenda W; Frey M; Waille S; Li Y; Lazar S; Matiya D; Miller WC; Hosseinipour MC BMC Pregnancy Childbirth; 2024 Oct; 24(1):648. PubMed ID: 39367352 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial. Kimani S; Painschab MS; Kaimila B; Kasonkanji E; Zuze T; Tomoka T; Mulenga M; Nyasosela R; Chikasema M; Mtangwanika A; Chawinga M; Mhango W; Nicholas S; Chimzimu F; Kampani C; Krysiak R; Lilly A; Randall C; Seguin R; Westmoreland KD; Montgomery ND; Fedoriw Y; Gopal S Lancet Glob Health; 2021 Jul; 9(7):e1008-e1016. PubMed ID: 34022150 [TBL] [Abstract][Full Text] [Related]
8. A combination SMS and transportation reimbursement intervention to improve HIV care following abnormal CD4 test results in rural Uganda: a prospective observational cohort study. Siedner MJ; Santorino D; Lankowski AJ; Kanyesigye M; Bwana MB; Haberer JE; Bangsberg DR BMC Med; 2015 Jul; 13():160. PubMed ID: 26149722 [TBL] [Abstract][Full Text] [Related]
9. Pediatric lymphoma patients in Malawi present with poor health-related quality of life at diagnosis and improve throughout treatment and follow-up across all Pediatric PROMIS-25 domains. Ellis GK; Chapman H; Manda A; Salima A; Itimu S; Banda G; Seguin R; Manda G; Butia M; Huibers M; Ozuah N; Tilly A; Stover AM; Basch E; Gopal S; Reeve BB; Westmoreland KD Pediatr Blood Cancer; 2021 Oct; 68(10):e29257. PubMed ID: 34339099 [TBL] [Abstract][Full Text] [Related]
10. Patient and nurse perspectives of a nurse-led community-based model of HIV care delivery in Malawi: a qualitative study. Sande O; Burtscher D; Kathumba D; Tweya H; Phiri S; Gugsa S BMC Public Health; 2020 May; 20(1):685. PubMed ID: 32410597 [TBL] [Abstract][Full Text] [Related]
11. An Intervention to Improve Uptake of Referrals for Children with Ear Disease or Hearing Loss in Thyolo District, Malawi: Acceptability and Feasibility. Baum A; Mulwafu W; Phiri M; Polack S; Bright T Int J Environ Res Public Health; 2019 Aug; 16(17):. PubMed ID: 31466419 [TBL] [Abstract][Full Text] [Related]
12. Characteristics and survival for HIV-associated multicentric Castleman disease in Malawi. Gopal S; Liomba NG; Montgomery ND; Moses A; Kaimila B; Nyasosela R; Chikasema M; Dhungel BM; Kampani C; Sanders MK; Krysiak R; Dittmer DP; Fedoriw Y J Int AIDS Soc; 2015; 18(1):20122. PubMed ID: 26242311 [TBL] [Abstract][Full Text] [Related]
13. Acceptability and feasibility of using a blended quality improvement strategy among health workers to monitor women engagement in Option B+ program in Lilongwe Malawi. Kumwenda W; Bengtson AM; Wallie S; Chikaonda T; Matoga M; Bula AK; Villiera JB; Kamanga E; Hosseinipour MC; Mwapasa V BMC Health Serv Res; 2024 Jul; 24(1):842. PubMed ID: 39061055 [TBL] [Abstract][Full Text] [Related]
14. Quantifying bias in survival estimates resulting from loss to follow-up among children with lymphoma in Malawi. Stanley CC; Westmoreland KD; Itimu S; Salima A; van der Gronde T; Wasswa P; Mtete I; Butia M; El-Mallawany NK; Gopal S Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27896944 [TBL] [Abstract][Full Text] [Related]
15. The effect of proactive, interactive, two-way texting on 12-month retention in antiretroviral therapy: Findings from a quasi-experimental study in Lilongwe, Malawi. Feldacker C; Klabbers RE; Huwa J; Kiruthu-Kamamia C; Thawani A; Tembo P; Chintedza J; Chiwaya G; Kudzala A; Bisani P; Ndhlovu D; Seyani J; Tweya H PLoS One; 2024; 19(8):e0298494. PubMed ID: 39208237 [TBL] [Abstract][Full Text] [Related]
16. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study. Westmoreland KD; Stanley CC; Montgomery ND; Kaimila B; Kasonkanji E; El-Mallawany NK; Wasswa P; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Chikasema M; Makwakwa V; Kampani C; Dhungel BM; Sanders MK; Krysiak R; Tomoka T; Liomba NG; Dittmer DP; Fedoriw Y; Gopal S Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27781380 [TBL] [Abstract][Full Text] [Related]
17. Achieving the first 90 for key populations in sub-Saharan Africa through venue-based outreach: challenges and opportunities for HIV prevention based on PLACE study findings from Malawi and Angola. Herce ME; Miller WM; Bula A; Edwards JK; Sapalalo P; Lancaster KE; Mofolo I; Furtado MLM; Weir SS J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25132. PubMed ID: 30033589 [TBL] [Abstract][Full Text] [Related]
18. Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi. Herce ME; Kalanga N; Wroe EB; Keck JW; Chingoli F; Tengatenga L; Gopal S; Phiri A; Mailosi B; Bazile J; Beste JA; Elmore SN; Crocker JT; Rigodon J J Int AIDS Soc; 2015; 18(1):19929. PubMed ID: 26028156 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of genital infections in medical inpatients in Blantyre, Malawi. Maher D; Hoffman I J Infect; 1995 Jul; 31(1):77-8. PubMed ID: 8522842 [TBL] [Abstract][Full Text] [Related]